vimarsana.com

Latest Breaking News On - Biosciences inc - Page 1 : vimarsana.com

Platinum Investment Management Ltd Has $606,000 Stock Holdings in Sagimet Biosciences Inc (NASDAQ:SGMT)

Platinum Investment Management Ltd. lowered its position in Sagimet Biosciences Inc. (NASDAQ:SGMT – Free Report) by 70.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 111,752 shares of the company’s stock after selling 272,161 shares during the period. Platinum Investment Management Ltd. owned 0.52% of Sagimet Biosciences […]

Aptose Biosciences (TSE:APS) Sets New 12-Month Low at $1 26

Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO)’s share price reached a new 52-week low on Friday . The stock traded as low as C$1.26 and last traded at C$1.26, with a volume of 1002 shares. The stock had previously closed at C$1.30. Aptose Biosciences Stock Performance The company has a market capitalization of […]

Insider Selling: IDEAYA Biosciences, Inc (NASDAQ:IDYA) Insider Sells 28,500 Shares of Stock

IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) insider Michael Anthony White sold 28,500 shares of the business’s stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $36.24, for a total value of $1,032,840.00. The sale was disclosed in a document filed with the Securities & Exchange […]

Willow Biosciences (TSE:WLLW) Shares Up 23 5%

Willow Biosciences Inc. (TSE:WLLW – Get Free Report)’s share price shot up 23.5% during trading on Thursday . The stock traded as high as C$0.11 and last traded at C$0.11. 436,630 shares were traded during mid-day trading, an increase of 614% from the average session volume of 61,150 shares. The stock had previously closed at […]

Aptose Biosciences (NASDAQ:APTO) Coverage Initiated at StockNews com

Equities research analysts at StockNews.com started coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Several other analysts also recently commented on APTO. HC Wainwright reaffirmed a “buy” rating and set a $23.00 […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.